Compounded semaglutide, dose-titrated by your provider. 10–15% average weight loss in clinical trials.
Treatment proceeds through up to 8 dose configurations. Your provider determines your starting point and titration pace. Every phase is $450 flat.
Most patients begin at Phase 1 or 2 for the initial escalation period, then progress based on response, side-effect tolerance, and weight-loss goals. Some patients stay at mid-range doses long-term; others titrate through to Phase 8. Your provider decides — and pricing stays the same.
If you miss 14 consecutive days without an injection, you will need to restart at the starting dose.
Medication is ordered and sent to your home address, 5–7 business days. No PO Boxes. Can ship to clinic for pickup if home delivery isn't possible.
Patients with a history or diagnosis of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN II) are not eligible to receive Semaglutide or Tirzepatide.